Ibn Sina Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 7.28%
(FY 2016)
- Profit -185.23%
(FY 2016)
- Ebitda -118.37%
(FY 2016)
- Net Worth -42.06%
(FY 2016)
- Total Assets 190.61%
(FY 2016)
About Ibn Sina Medicare
The Corporate was formerly known as Ibn Sina Medical Tourism Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hayder Algburi, Mercy Riengsete, and Murtadha Gburi serve as directors at the Company.
- CIN/LLPIN
U85110DL2011PTC224767
- Company No.
224767
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2011
- Date of AGM
11 Nov 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ibn Sina Medicare Private Limited offer?
Ibn Sina Medicare Private Limited offers a wide range of products and services, including Medical Treatment Services, Vehicle Rental, Pick Up Service, Accommodation Services, Tour Packages, Medical Tourism, Language Interpretation Services.
Who are the key members and board of directors at Ibn Sina Medicare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hayder Algburi  | Director | 08-Sep-2011 | Current |
Mercy Riengsete  | Director | 01-May-2013 | Current |
| Murtadha Gburi | Additional Director | 23-Mar-2015 | Current |
Financial Performance of Ibn Sina Medicare.
Ibn Sina Medicare Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 7.28% increase. The company also saw a substantial fall in profitability, with a 185.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ibn Sina Medicare?
In 2016, Ibn Sina Medicare had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ishtar Gate International Private LimitedActive 3 years 10 monthsHayder Algburi and Murtadha Gburi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibn Sina Medicare?
Ibn Sina Medicare has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibn Sina Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibn Sina Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
